Roche trumps rivals with strongest biotech patent portfolio
Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.